Search
Contract Management: Tools for Improving Commercial Contract Processes Within Organizations Often times in-house counsel is responsible for oversight of negotiation, drafting, tracking, modification, and renewal of a high volume of commercial agreements, frequently working internally with non-legal...
Partner Jonathan Havens will co-chair the 2023 FDLI Annual Conference. As the premier conference for the food and drug law community, the FDLI Annual Conference addresses complex legal, regulatory, compliance, and policy issues in all facets of the FDA-regulated industry. The conference provides in...
Zachary Kobrin spoke on a panel titled, “Private Equity Perspectives: A Look Into Investment Strategies for 2023 and Beyond” at the 3rd Annual Cannalaw Virtual Summit, presented by Inside Practice and the Cannalaw Network. Panelists discussed investment strategies, the importance of advisory...
Brownfields Redevelopment: A CREW NJ Lunch and Learn Melissa Clarke joins CREW NJ and commercial real estate professionals to discuss the tools and resources necessary to redevelop brownfield sites -- properties that are abandoned or underutilized because of either real or perceived contamination.
Brave New World – Emerging Standards for Safety and Health in the Cannabis Industry Partners Jonathan Havens and Michael Metz-Topodas will be speaking during a CLE Webinar about emerging standards in the cannabis industry. Topics for Discussion include: Overview of the cannabis process and health...
On Friday, April 21, 2023, Gov. John Carney issued a press release indicating he would not veto two legalization bills on his desk as he did one year ago, and they would go into effect on Sunday, April 23, 2023. Sources suggest that, unlike last year, the Democratic-controlled General Assembly would...
Partner Richard "Shark" Forsten will speak on panel regarding the coming New Castle County county-wide property tax reassessment.
Cannabis Basics: Getting up to Speed with Current Laws, Legislation, & Essential Business Issues The cannabis and hemp industries in the U.S. have exploded in recent years due to increased numbers of states allowing businesses to grow, process, and sell cannabis products for medical and adult use...
On March 7, 2023 the U.S. Department of Housing and Urban Development (the “HUD”) Secretary, Marcia L. Fudge, issued a public memorandum (the “Memo”) expressing concern over a lack of transparency in fees charged to residential tenants. The Memo calls on housing providers and state and local...
Breaking Into the Cannabis Market: Balancing the Profits Against the Risks of Non-Compliance In October 2022, the Biden Administration announced that it would begin pardoning all prior offences of simple possession of marijuana and asked that DEA and FDA begin the administrative process to review...
On February 28, 2023, the Federal Trade Commission (“FTC”) and Consumer Financial Protection Bureau (“CFPB”) issued a Request for Information (“RFI”) seeking public comment on background screening issues affecting rental housing applicants and tenants in the United States. The 10-page RFI, which the...
Adam Fayne will be moderating a panel at the Cannabis & Psychedelics Investment Summit in Miami, Florida on February 27, 2023. The panel topic will be Investment 101 for Family Offices: An Introduction to investing in cannabis and psychedelics.
Saul Ewing attorneys, Sean O’Neill and Michael Gold , discuss new ESG regulations in connection with the Real Estate industry and Real Estate Investment Trusts (REITs). New regulations from the U.S. Department of Labor and proposed regulations from the Securities & Exchange Commission have created...
Zachary Kobrin spoke on a panel titled, “Opportunities and Challenges in the 2023 Cannabis Market” presented by Centri Business Consulting. This webinar featured a panel of experts discussing trending financial topics in the cannabis industry including: Recent updates in Capital Markets & SAFE...
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.